MeVis Medical Solutions AG (M3V.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In EUR
| Market Cap | 45.14M |
| Enterprise Value | 38.61M |
| P/E Ratio | 17.88 |
| PEG Ratio | -0.71 |
| Price/Sales Ratio | 5.09 |
| Price/Book Ratio | 2.41 |
| Enterprise/Revenue | 4.66 |
| Enterprise/EBITDA | 22.38 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.28 |
| Operating Margin | 0.32 |
| Return On Assets | 0.1 |
| Return On Equity | 0.13 |
| Revenue | 16.06M |
| Revenue/Share | 4.64 |
| Gross Profit | 15.69M |
| EBITDA | 3.43M |
| Net Income | 3.17M |
| Diluted EPS | 1.74 |
| Total Cash | 3.65M |
| Total Cash/Share | 2.01 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.27 |
| Book Value Per Share | 9.79 |
| 52-Week Change | -4.07 |
| 52-Week High | 26.8 |
| 52-Week Low | 22.2 |
| Moving Average 50 Days | 23.27 |
| Moving Average 200 Days | 24.41 |
| Average Volume | 42 |
| Shares Outstanding | 1.82M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.95 |
| Trailing Annual Dividend Yield | 4.03 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |